MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

Abstract:

:MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molecular mechanism of miR-330 in determining the aggressiveness of human prostate cancer has not been studied. Here, we show that miR-330 is significantly lower expressed in human prostate cancer cell lines than in nontumorigenic prostate epithelial cells. Bioinformatics analyses reveal a conserved target site for miR-330 in the 3'-untranslated region (UTR) of E2F1 at nucleotides 1018-1024. MiR-330 significantly suppressed the activity of a luciferase reporter containing the E2F1-3'-UTR in the cells. This activity could be abolished with the transfection of anti-miR-330 or mutated E2F1-3'-UTR. In addition, the expression level of miR-330 and E2F1 was inversely correlated in cell lines and prostate cancer specimens. After overexpressing of miR-330 in PC-3 cells, cell growth was suppressed by reducing E2F1-mediated Akt phosphorylation and thereby inducing apoptosis. Collectively, this is the first study to show that E2F1 is negatively regulated by miR-330 and also show that miR-330 induces apoptosis in prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

journal_name

Oncogene

journal_title

Oncogene

authors

Lee KH,Chen YL,Yeh SD,Hsiao M,Lin JT,Goan YG,Lu PJ

doi

10.1038/onc.2009.192

subject

Has Abstract

pub_date

2009-09-24 00:00:00

pages

3360-70

issue

38

eissn

0950-9232

issn

1476-5594

pii

onc2009192

journal_volume

28

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate.

    abstract::Treatment of mouse (12)1/CA cells with adriamycin or irradiation with U.V.C. induces p53-dependent transcription of a beta-galactosidase reporter and the endogenous p21/Waf1/Cip1 gene. Despite the induction of Waf1, the cells arrest only transiently in G1 or G2, then resume growth and eventually undergo apoptosis. In ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201104

    authors: Chernov MV,Stark GR

    更新日期:1997-05-29 00:00:00

  • Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.

    abstract::Cyclooxygenase-2 (COX-2) is involved in diverse processes such as inflammation, carcinogenesis and apoptosis. As COX-2 inhibitors interfere with these processes, inhibition of COX-2 has been suggested as a promising anticancer treatment. However, the role of COX-2 in modulation of apoptosis as well as the death pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206837

    authors: Totzke G,Schulze-Osthoff K,Jänicke RU

    更新日期:2003-09-11 00:00:00

  • Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.

    abstract::Mutant p53 frequently accumulates in cancer cells and promotes tumor cell invasion, as part of its gain of function. Its accumulation is partially due to enhanced stability, but little is known about how the mRNA levels of mutant p53 can be regulated. Likewise, the impact of cancer therapy on the levels of mutant p53 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.72

    authors: Bug M,Dobbelstein M

    更新日期:2011-08-18 00:00:00

  • Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

    abstract::Abundant data support a key role for the transcription factor nuclear factor-kappaB (NF-kappaB) signaling pathway in controlling the initiation and progression of human cancer. NF-kappaB and associated regulatory proteins such as IkappaB kinase (IKK) are activated downstream of many oncoproteins and there is much evid...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209942

    authors: Bassères DS,Baldwin AS

    更新日期:2006-10-30 00:00:00

  • Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

    abstract::A lot of attention has been dedicated to investigate the role of the tyrosine kinase receptor MET in tumors. The acquired notion that cancer cells from different histological origin strictly rely on the engagement of this specific oncogene for their growth and survival has certainly justified the development and the u...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.36

    authors: Finisguerra V,Prenen H,Mazzone M

    更新日期:2016-10-20 00:00:00

  • Functional interaction between the small GTP-binding protein Rin and the N-terminal of Brn-3a transcription factor.

    abstract::Brn-3a is a transcription factor belonging to the class IV of POU domain transcription factors. It is expressed throughout the peripheral nervous system but especially in postmitotic sensory neurons of dorsal root ganglia. Brn-3a is known to regulate different genes involved in neuronal differentiation and survival. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206635

    authors: Calissano M,Latchman DS

    更新日期:2003-08-21 00:00:00

  • Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21.

    abstract::The death mediator caspase acts as the dominant regulator during cell death induction. The CPP32 subfamily, including caspase 3 (CPP32/Yama/Apopain), is essential for the cell death signaling. We recently reported that activation of caspase 3 is regulated by complex formation with p21 or ILP. In the present study, we ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202409

    authors: Suzuki A,Tsutomi Y,Miura M,Akahane K

    更新日期:1999-02-04 00:00:00

  • The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues.

    abstract::We previously showed that the proto-oncogene RON encodes the tyrosine kinase receptor for Macrophage Stimulating Protein (MSP), originally isolated as a chemotactic factor for peritoneal macrophages. To elucidate the biological role of MSP we studied the expression of the Ron receptor in vivo, and the response to the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gaudino G,Avantaggiato V,Follenzi A,Acampora D,Simeone A,Comoglio PM

    更新日期:1995-12-21 00:00:00

  • Differential response of the Ras exchange factor, Ras-GRF to tyrosine kinase and G protein mediated signals.

    abstract::Ras-GRF, a guanine-nucleotide exchange factor that activates Ras p21, was tested for its ability to couple to either tyrosine kinase or heterotrimeric G protein signal transduction pathways. Ras-GRF failed to bind the SH2 and SH3 containing adaptor protein Grb2, either in vitro or in vivo. Furthermore, Ras-GRF did not...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shou C,Wurmser A,Suen KL,Barbacid M,Feig LA,Ling K

    更新日期:1995-05-18 00:00:00

  • Cell-cycle progression is not essential for c-Myc to block differentiation.

    abstract::The c-myc proto-oncogene has been shown to cause blockages to differentiation in many cell lineages. Although the mechanism by which c-Myc affects this process remains unknown, it is considered that it might result indirectly as an outcome of the continued cell-cycle progression invoked by c-Myc in cells which must gr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201124

    authors: Ryan KM,Birnie GD

    更新日期:1997-06-12 00:00:00

  • CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

    abstract::The serine threonine checkpoint kinase 2 (CHK2) is a critical protein involved in the DNA damage-response pathway, which is activated by phosphorylation inducing cellular response such as DNA repair, cell-cycle regulation or apoptosis. Although CHK2 activation mechanisms have been amply described, very little is known...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.495

    authors: García-Limones C,Lara-Chica M,Jiménez-Jiménez C,Pérez M,Moreno P,Muñoz E,Calzado MA

    更新日期:2016-08-18 00:00:00

  • miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.

    abstract::The disabled homolog 2 (DAB2) gene was recently identified as a tumor suppressor gene with its expression downregulated in multiple cancer types. The role of DAB2 in lung tumorigenesis, however, is not fully characterized, and the mechanisms of DAB2 dysregulation in lung cancer are not defined. Here we show that low D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.381

    authors: Du L,Zhao Z,Ma X,Hsiao TH,Chen Y,Young E,Suraokar M,Wistuba I,Minna JD,Pertsemlidis A

    更新日期:2014-08-21 00:00:00

  • The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells.

    abstract::Cancer stem cells are believed to be responsible for tumor initiation and development. Much current research on human brain tumors is focused on the stem-like properties of glioblastoma stem cells (GSCs). However, little is known about the molecular mechanisms of cell cycle regulation that discriminate between GSCs an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.399

    authors: Koyama-Nasu R,Nasu-Nishimura Y,Todo T,Ino Y,Saito N,Aburatani H,Funato K,Echizen K,Sugano H,Haruta R,Matsui M,Takahashi R,Manabe E,Oda T,Akiyama T

    更新日期:2013-08-15 00:00:00

  • p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.

    abstract::The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0697-6

    authors: Chang HW,Kim MR,Lee HJ,Lee HM,Kim GC,Lee YS,Nam HY,Lee M,Jang HJ,Lee KE,Lee JC,Byun Y,Kim SW,Kim SY

    更新日期:2019-05-01 00:00:00

  • All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

    abstract::Wilms tumor is one of the most frequent neoplasias in children. Our previous microarray screening in a large series of Wilms tumors revealed several candidate genes that are deregulated in advanced tumors and are part of the retinoic acid signaling pathway. To investigate whether retinoic acid could be employed as a n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208725

    authors: Zirn B,Samans B,Spangenberg C,Graf N,Eilers M,Gessler M

    更新日期:2005-08-04 00:00:00

  • AP-1--Introductory remarks.

    abstract::This issue attempts to give a 'state of the art' overview of the AP-1 transcription factor family, a fundamental class of transcriptional regulators. The AP-1 family consists of several bZIP (basic region leucine zipper) domain proteins, the Jun, the Fos, and the ATF subfamilies, which all have to dimerize before they...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204416

    authors: Wagner EF

    更新日期:2001-04-30 00:00:00

  • Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.

    abstract::Clinical and epidemiological data support a role for human papilloma virus (HPV) type 16 in the pathogenesis of cervical carcinoma. The W12 cell line contains HPV16 sequences, predominantly as a high copy number episome, and is immortalised in vitro, but non-tumourigenic. A morphologically distinct sub-line of the par...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crook T,Greenfield I,Howard J,Stanley M

    更新日期:1990-04-01 00:00:00

  • The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.

    abstract::The past three decades have seen an unremitting quest to identify and understand gastrointestinal stem cells, their plasticity in differentiating across cell types, as well as their role in normal, regenerative, and cancer cells. A fascinating hallmark of stem cells is their ability to undergo assymetric cell division...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208924

    authors: Mishra L,Shetty K,Tang Y,Stuart A,Byers SW

    更新日期:2005-08-29 00:00:00

  • Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.

    abstract::In the present study, we have analysed the effects of transforming growth factor-beta (TGF-beta) signaling on the growth behavior of pancreatic carcinoma cells in vitro and on their tumorigenicity in vivo. Ectopic expression of dominant-negative mutants of the TGF-beta type II receptor or type I receptor/activin recep...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210272

    authors: Schniewind B,Groth S,Sebens Müerköster S,Sipos B,Schäfer H,Kalthoff H,Fändrich F,Ungefroren H

    更新日期:2007-07-19 00:00:00

  • P150c-abl is detected in mouse male germ cells by an in vitro kinase assay and is associated with stage-specific phosphoproteins in haploid cells.

    abstract::We have utilized c-abl antibodies and an in vitro kinase assay to identify the protein products of the c-abl gene in mouse testis. Although the testis contains high levels of a unique c-abl mRNA, along with lower amounts of two c-abl mRNAs common to somatic cells, we detected only a single polypeptide of approximately...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ponzetto C,Wadewitz AG,Pendergast AM,Witte ON,Wolgemuth DJ

    更新日期:1989-06-01 00:00:00

  • Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.

    abstract::Nucleophosmin (NPM) is a nucleus-cytoplasmic shuttling protein that is implicated in centrosome duplication, cell cycle progression and stress response. At the steady state, NPM localizes mainly in the nucleolus, where it forms a complex with different cellular proteins. One-third of acute myeloid leukemias (AML) are ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209453

    authors: Mariano AR,Colombo E,Luzi L,Martinelli P,Volorio S,Bernard L,Meani N,Bergomas R,Alcalay M,Pelicci PG

    更新日期:2006-07-20 00:00:00

  • Translation of p15.5INK4B, an N-terminally extended and fully active form of p15INK4B, is initiated from an upstream GUG codon.

    abstract::The expression of the cyclin-dependent kinase inhibitor p15INK4B in normal cells after induction with TGF-beta1, or following overexpression from an adenovirus-encoded cDNA, appears on an SDS-polyacrylamide gel as a doublet. Here, the underlying mechanism behind the synthesis of the two species has been studied. By ex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203496

    authors: Fuxe J,Raschperger E,Pettersson RF

    更新日期:2000-03-23 00:00:00

  • F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.

    abstract::Cellular adhesion to extracellular matrix is a central phenomenon for the maintenance of tissue integrity and cellular movement. Collectively, these processes are regulated by a fine-tuned balance between the formation and loosening of adhesive contacts, a process involving integrins, and the elevation and diminution ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210883

    authors: Sales KJ,Boddy SC,Jabbour HN

    更新日期:2008-04-10 00:00:00

  • Deletions of the p16 gene in pediatric leukemia and corresponding cell lines.

    abstract::The p16 gene (MTS1 or CDK4I) encoding an inhibitor of cyclin-dependent kinase 4 (cdk4), has been reported to be deleted in various tumor cell lines, including lines derived from leukemic cells. The reported frequency of p16 gene loss is much higher in established cell lines than in primary tumor specimens. We investig...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kees UR,Ranford PR,Hatzis M

    更新日期:1996-05-16 00:00:00

  • Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.

    abstract::We have previously reported on the identification of a cDNA (placenta growth factor, PlGF) coding for a novel angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). Biochemical and functional characterization of PlGF derived from t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maglione D,Guerriero V,Viglietto G,Ferraro MG,Aprelikova O,Alitalo K,Del Vecchio S,Lei KJ,Chou JY,Persico MG

    更新日期:1993-04-01 00:00:00

  • Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors.

    abstract::Chromatin remodeling proteins regulate multiple aspects of cell homeostasis, making them ideal candidates for misregulation in transformed cells. Here, we explore Sin3A, a member of the Sin3 family of proteins linked to tumorigenesis that are thought to regulate gene expression through their role as histone deacetylas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.326

    authors: Das TK,Sangodkar J,Negre N,Narla G,Cagan RL

    更新日期:2013-06-27 00:00:00

  • R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.

    abstract::Within the superfamily of ras-related GTP-binding proteins, only ras itself has been shown to act as an oncogene. Seven other proteins, however, have greater than 50% amino acid identity to ras and one of them, rap1A, has been shown to interact with the ras GTPase activating protein, ras-GAP, and to inhibit ras functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rey I,Taylor-Harris P,van Erp H,Hall A

    更新日期:1994-03-01 00:00:00

  • Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.

    abstract::The tumor suppressor gene phosphatase and tensin homologue (PTEN) regulates the phosphatidylinositol-3'-kinase (PI3K) signaling pathway and has been shown to correlate with poor prognosis in high-grade astrocytomas when mutational inactivation or loss of the PTEN gene occurs. PTEN mutation leads to constitutive activa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208427

    authors: Edwards LA,Thiessen B,Dragowska WH,Daynard T,Bally MB,Dedhar S

    更新日期:2005-05-19 00:00:00

  • Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation.

    abstract::ATM is a member of the large phosphatidylinositol-3 kinase family and plays an important role in cellular response to DNA damage. To further define the physiological roles of ATM at the cellular level, we created an isogenic set of stable cell lines differing only in their ATM status from the chicken B cell line DT40 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203172

    authors: Takao N,Kato H,Mori R,Morrison C,Sonada E,Sun X,Shimizu H,Yoshioka K,Takeda S,Yamamoto K

    更新日期:1999-11-25 00:00:00

  • p53-dependent downregulation of metastasis-associated laminin receptor.

    abstract::Based on observations suggesting a role for the tumor suppressor protein p53 in regulating expression of the 67-kDa laminin receptor precursor, 37LRP, we analysed the 37LRP promoter activity in a wild-type p53 (wt p53) ovarian carcinoma cell line and in a cisplatin-resistant subline with mutated p53. We observed an in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205957

    authors: Modugno M,Tagliabue E,Ardini E,Berno V,Galmozzi E,De Bortoli M,Castronovo V,Ménard S

    更新日期:2002-10-24 00:00:00